DEFINITIVE PROXY STATEMENT

Company

Pasithea Therapeutics Corp.

Filed

December 29, 2025

Period of Report

January 28, 2026

Accession Number

0001213900-25-126111

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →